Foxp3+ Treg were also downregulated in Gal-9 knock-out mice engrafted with C1498 AML cells, hinting that galectin-9 (ligand for TIM-3) may be engaged in expansion of Treg in AML [185]. The gene discussed is HAVCR2; the disease is acute myeloid leukemia.